Clinical trials
Recruiting Fallopian Tube Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Gynecologic Oncology Group | 3 |
| AstraZeneca | 2 |
| Beijing Biotech | 2 |
| Genmab | 2 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Hansoh BioMedical R&D Company | 1 |
| NextCure, Inc. | 1 |
| Peking University Cancer Hospital & Institute | 1 |
| Peking University People's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 20 |
| Ovarian Neoplasms | 14 |
| Carcinoma, Ovarian Epithelial | 8 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Endometrial Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Recurrence | 2 |
| Uterine Cervical Neoplasms | 2 |
| Carcinoma, Renal Cell | 1 |
| Lung Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.